SYT-SSX Fusion Genes and Prognosis in Synovial Sarcoma
Author Information
Author(s): Mezzelani A, Mariani L, Tamborini E, Agus V, Riva C, Lo Vullo S, Fabbri A, Stumbo M, Azzarelli A, Casali P G, Gronchi A, Sozzi G, Pierotti M A, Pilotti S
Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumori
Hypothesis
The study investigates the correlation between SYT-SSX fusion transcripts and prognosis in synovial sarcoma.
Conclusion
The SYT-SSX1 fusion transcript is associated with reduced metastasis-free survival, although it did not reach statistical significance.
Supporting Evidence
- The SYT-SSX1 fusion transcript is an independent prognostic factor.
- There was a borderline p-value of 0.067 between the SYT-SSX1 transcript and the biphasic subtype.
- In a larger analysis of 70 cases, the association became significant.
Takeaway
This study looked at a type of cancer called synovial sarcoma and found that a specific gene fusion might help predict how well patients will do, but the results weren't strong enough to be sure.
Methodology
A case series of 64 synovial sarcomas was analyzed for SYT-SSX fusion transcripts to correlate molecular data with prognosis and morphology.
Limitations
The study could not confirm the predictive value of the biphasic subtype for the presence of the SYT-SSX1 transcript.
Statistical Information
P-Value
0.183
Statistical Significance
p=0.183
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website